Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ)
- Previous Close
52.30 - Open
52.10 - Bid 51.95 x --
- Ask 51.99 x --
- Day's Range
51.90 - 52.47 - 52 Week Range
49.01 - 97.20 - Volume
1,734,684 - Avg. Volume
3,615,008 - Market Cap (intraday)
40.787B - Beta (5Y Monthly) -0.43
- PE Ratio (TTM)
22.18 - EPS (TTM)
2.34 - Earnings Date Apr 26, 2025
- Forward Dividend & Yield 1.00 (1.93%)
- Ex-Dividend Date May 15, 2024
- 1y Target Est
71.54
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
www.snibe.comRecent News: 300832.SZ
View MorePerformance Overview: 300832.SZ
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300832.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300832.SZ
View MoreValuation Measures
Market Cap
40.79B
Enterprise Value
38.31B
Trailing P/E
22.17
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.79
Price/Book (mrq)
4.53
Enterprise Value/Revenue
8.26
Enterprise Value/EBITDA
18.22
Financial Highlights
Profitability and Income Statement
Profit Margin
39.66%
Return on Assets (ttm)
13.17%
Return on Equity (ttm)
21.68%
Revenue (ttm)
4.64B
Net Income Avi to Common (ttm)
1.84B
Diluted EPS (ttm)
2.34
Balance Sheet and Cash Flow
Total Cash (mrq)
2.48B
Total Debt/Equity (mrq)
0.04%
Levered Free Cash Flow (ttm)
410.78M